Jul 24, 2025
Simulations Plus (SLP:NASDAQ) Fiscal Fumble Triggers 26% Stock Crash | Dog of the Week
SLP:NASDAQ is the Dog of the Week after a brutal stock crash—down 70% over the past year and 26% in a single day following its Q3 earnings and slashed 2025 revenue guidance. Despite operating in the promising space of AI drug discovery and biosimulation, the company reported a massive $67M loss driven by a non-cash impairment and weak organic growth. Brett breaks down the earnings, forecast changes, and what this means for investors in biotech stocks. Is SLP stock still worth watching or one to avoid?